#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraneoplastic neurological syndrome Epstein-Barr virus associated lymphoproliferative disorder Hypotransferrinaemia Adenovirus infection Mantle cell lymphoma refractory Congenital growth hormone deficiency Stevens-Johnson syndrome Stress cardiomyopathy Follicular lymphoma stage II Fibrous dysplasia of bone Arrhythmogenic right ventricular dysplasia Stiff person syndrome Cystic fibrosis respiratory infection suppression Non-small cell lung cancer recurrent Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Life with Disease Angelman’s syndrome – Treatment Pemphigoid – Diagnostics Shprintzen-Goldberg syndrome – Trials in Disease Chondrosarcoma Inclusion body myositis – Treatment Pleomorphic leiomyosarcoma – Basic Information Rosai-Dorfman syndrome – Trials in Disease Combined immunodeficiency – Treatment Congenital hypotransferrinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ACICLOVIR SODIUM Germanium (68Ge) Chloride Afatinib Trometamol Sunvozertinib Triptorelin Pamoate Methadone Hydrochloride Glycopyrronium Bromide Eye103 Imetelstat Sodium Oseltamivir Ltp001 Pf-07220060 Monohydrate 4-IODOPHENYLALANINE I-131 Isavuconazonium Sulfate Wt1 Mrna Dc Folic Acid Bupivacaine Ly3484356 PRILOCAINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Myopia Diabetic ketoacidosis Pancreatic failure Myeloproliferative neoplasm Leukocyte adhesion deficiency Hepatotoxicity Herpes simplex meningitis Prostate cancer metastatic Osteosarcoma External cephalic version Dermatitis atopic Chronic hepatitis C Hot flush Arginase deficiency Haemoptysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatitis alcoholic

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Prednisolone Metasulfobenzoate Sodium
    • Acetylcysteine
    • Prednisolone
    France

  • Study on the Effects of Alpha-1 Antitrypsin and Prednisolone in Patients with Severe Alcohol-Related Hepatitis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    • Prednisolone
    Austria

  • Study on the Effectiveness of N-Acetylcysteine and Methylprednisolone for Patients with Severe Acute Alcoholic Hepatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone Acetate
    • Acetylcysteine
    Spain

  • Study on the Safety and Effects of Resatorvid and Filgrastim for Patients with Severe Alcoholic Hepatitis and Acute-on-Chronic Liver Failure

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    • Acute on chronic liver failure
    Investigated Drugs:
    • Resatorvid
    • Filgrastim
    • Placebo
    Germany Portugal Spain

  • Study on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Int-787
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!